CD36 and cardiomyopathy: Furthermore, cardiomyopathy in this model can be exacerbated by increasing the circulating non-esterified fatty acids (high fat diet) [88] or by diminishing FAT/CD36 (this increases circulating fatty acids), when MHC-PPARα mice were crossed with mice deficient for CD36 [89].